Advertisement

Management of peripheral arterial disease in the modern era: an internist “Cup of Tea”

  • Marco ProiettiEmail author
IM - COMMENTARY
  • 25 Downloads

Peripheral arterial disease (PAD), intended as the atherosclerotic occlusive disease of the lower extremities, represents a relevant vascular condition which has been estimated to affect more than 200 million people worldwide [1]. Epidemiological data showed how prevalence and incidence sharply increase with age, affecting a substantial proportion of elderly and very elderly subjects (> 20% in subjects > 80 years old), both referring to symptomatic and asymptomatic clinical presentation [1].

In the 2017 European Society of Cardiology (ESC) guidelines on the management of PAD [2] the term ‘peripheral arterial diseases’ has been extended to include a pathological condition of any vascular site. Conversely, to indicate the classical PAD, the term ‘Lower Extremity Arterial Disease’ (LEAD) has been preferred.

To date, the clinical management of patients with symptomatic PAD stands on some pivotal pillars. In the recent issue of the clinical guidelines, the authors established the “best...

Notes

Compliance with ethical standards

Conflict of interest

The author declare no conflict of interest related to this paper.

Statements on human and animal rights

This article does not contain any studies with human participants or animals performed by the author.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Criqui MH, Aboyans V (2015) Epidemiology of peripheral artery disease. Circ Res 116:1509–1526.  https://doi.org/10.1161/CIRCRESAHA.116.303849 CrossRefPubMedGoogle Scholar
  2. 2.
    Aboyans V, Ricco J-B, Bartelink M-LEL et al (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 39:763–816.  https://doi.org/10.1093/eurheartj/ehx095 CrossRefPubMedGoogle Scholar
  3. 3.
    Parmenter BJ, Dieberg G, Smart NA (2015) Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sport Med 45:231–244.  https://doi.org/10.1007/s40279-014-0261-z CrossRefGoogle Scholar
  4. 4.
    Parmenter BJ, Dieberg G, Phipps G, Smart NA (2015) Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med 20:30–40.  https://doi.org/10.1177/1358863X14559092 CrossRefPubMedGoogle Scholar
  5. 5.
    Hageman D, Fokkenrood HJ, Gommans LN et al (2018) Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev 4:CD005263.  https://doi.org/10.1002/14651858.CD005263.pub4 CrossRefPubMedGoogle Scholar
  6. 6.
    Lamberti N, López-Soto PJ, Guerzoni F et al (2019) Changes in exercise capacity and risk of all-cause mortality in patients with peripheral artery disease: a 10-year retrospective cohort study. Intern Emerg Med.  https://doi.org/10.1007/s11739-019-02176-3 CrossRefPubMedGoogle Scholar
  7. 7.
    Raparelli V, Pastori D, Pignataro SF et al (2018) Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. Intern Emerg Med.  https://doi.org/10.1007/s11739-018-1835-9 CrossRefPubMedGoogle Scholar
  8. 8.
    Eikelboom JW, Connolly SJ, Bosch J et al (2017) Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377:1319–1330.  https://doi.org/10.1056/NEJMoa1709118 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Borges WR, de Carvalho ATY, Junior RA (2017) Predictors of major amputation. Intern Emerg Med 12:1079–1080.  https://doi.org/10.1007/s11739-017-1652-6 CrossRefPubMedGoogle Scholar
  10. 10.
    Anand SS, Caron F, Eikelboom JW et al (2018) Major adverse limb events and mortality in patients with peripheral artery disease: The COMPASS Trial. J Am Coll Cardiol 71:2306–2315.  https://doi.org/10.1016/j.jacc.2018.03.008 CrossRefPubMedGoogle Scholar
  11. 11.
    Huang B-T, Peng Y, Huang F-Y et al (2017) Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease. Intern Emerg Med 12:1121–1129.  https://doi.org/10.1007/s11739-017-1694-9 CrossRefPubMedGoogle Scholar
  12. 12.
    Kramer MHH, Bauer W, Dicker D et al (2014) The changing face of internal medicine: patient centred care. Eur J Intern Med 25:125–127.  https://doi.org/10.1016/j.ejim.2013.11.013 CrossRefPubMedGoogle Scholar

Copyright information

© Società Italiana di Medicina Interna (SIMI) 2019

Authors and Affiliations

  1. 1.Department of Clinical Sciences and Community HealthUniversity of MilanMilanItaly
  2. 2.Geriatric UnitFondazione IRCCS Ca’ Granda, Ospedale Maggiore PoliclinicoMilanItaly
  3. 3.Liverpool Centre for Cardiovascular ScienceUniversity of Liverpool and Liverpool Heart and Chest HospitalLiverpoolUK

Personalised recommendations